Erythroleukemia cells: variants inducible for hemoglobin synthesis without commitment to terminal cell division

Area of Science:

• Cell Biology
• Hematopoiesis
• Molecular Biology

Background:

• Murine erythroleukemia cells (MELC) are a valuable model for studying erythroid differentiation.
• These cells are blocked at a precursor stage similar to erythroid colony-forming units (CFU-e).
• Terminal differentiation involves coordinated gene expression, cell division commitment, and hemoglobin accumulation.

Purpose of the Study:

• To investigate the differentiation characteristics of two inducer-resistant MELC variants, DR10 and R1.
• To analyze the commitment to terminal cell division and hemoglobin accumulation in response to various chemical inducers.
• To understand the regulatory mechanisms of erythroid differentiation using these variant cell lines.

Main Methods:

• Development of inducer-resistant MELC variants (DR10, R1) from sensitive DS19 cells.
• Culture of MELC variants with chemical inducers: dimethyl sulfoxide (Me2SO), hexamethylene bisacetamide (HMBA), and butyric acid.
• Assessment of commitment to terminal cell division and accumulation of hemoglobin and H1(0) protein.

Main Results:

• DR10 and R1 cells are commitment-negative, failing to commit to terminal cell division with Me2SO, HMBA, or butyric acid.
• Both variants accumulate the chromatin protein H1(0) in response to all tested inducers.
• DR10 shows resistance to Me2SO-induced hemoglobin accumulation but sensitivity to HMBA/butyric acid.
• R1 exhibits resistance to Me2SO and HMBA but sensitivity to butyric acid for hemoglobin accumulation.

Conclusions:

• DR10 and R1 represent commitment-negative MELC variants with distinct patterns of differentiation response.
• These variants provide a tool to dissect the specific pathways regulating hemoglobin synthesis versus commitment.
• Further study of these cell lines can elucidate factors controlling terminal erythroid differentiation.